Advertisement

Gestational Diabetes

  • H. David McIntyre
  • Catherine Baskerville
  • Jeremy J. N. Oats
Chapter

Abstract

Gestational Diabetes (GDM) is a common complication of pregnancy, reflecting inadequate beta cell compensation in the face of pregnancy-related insulin resistance. The prevalence and severity of GDM reflects the population rate of Type 2 diabetes in young women and is generally increasing with the advance of the global obesity epidemic. This article reviews the diagnosis of GDM, the importance of specific underlying diagnoses and traditional and alternative approaches to therapy. Evidence regarding the benefits of GDM treatment is summarized and perinatal management reviewed.

Keywords

Oral Glucose Tolerance Test Gestational Diabetes Shoulder Dystocia Oral Hypoglycaemic Agent Brachial Plexus Palsy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Hadden DR, Hillebrand B. The first recorded case of diabetic pregnancy (Bennewitz HG, 1824, University of Berlin). Diabetologia. 1989;32(8):625.PubMedCrossRefGoogle Scholar
  2. 2.
    Miller HC. The effect of diabetic and prediabetic pregnancies on the fetus and newborn infant. J Pediatr. 1946;29(4):455–61. Epub 1946/10/01.PubMedCrossRefGoogle Scholar
  3. 3.
    Carrington ER, Shuman CR, Reardon HS. Evaluation of the prediabetic state during pregnancy. Obstet Gynecol. 1957;9(6):664–9. Epub 1957/06/01.PubMedCrossRefGoogle Scholar
  4. 4.
    O'Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes. 1964;13:278–85. Epub 1964/05/01.PubMedGoogle Scholar
  5. 5.
    Freinkel N. Banting lecture 1980. Diabetes. 1980;29(12):1023–35. Epub 1980/12/01.PubMedCrossRefGoogle Scholar
  6. 6.
    Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.PubMedCrossRefGoogle Scholar
  7. 7.
    Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82. Epub 2010/03/02.PubMedCrossRefGoogle Scholar
  8. 8.
    Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, et al. The Hyperglycemia and Adverse Pregnancy Outcome Study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care. 2012;35:740–6. Epub 2012/02/24.CrossRefGoogle Scholar
  9. 9.
    Pedersen J, Bojsen-Moller B, Poulsen H. Blood sugar in newborn infants of diabetic mothers. Acta Endocrinol (Copenh). 1954;15(1):33–52.Google Scholar
  10. 10.
    Sacks DA, Greenspoon JS, Abu-Fadil S, Henry HM, Wolde-Tsadik G, Yao JF. Toward universal criteria for gestational diabetes: the 75-gram glucose tolerance test in pregnancy. Am J Obstet Gynecol. 1995;172(2 Pt 1):607–14. Epub 1995/02/01.PubMedCrossRefGoogle Scholar
  11. 11.
    Omori Y, Jovanovic L. Proposal for the reconsideration of the definition of gestational diabetes. Diabetes Care. 2005;28(10):2592–3.PubMedCrossRefGoogle Scholar
  12. 12.
    van Leeuwen M, Louwerse MD, Opmeer BC, Limpens J, Serlie MJ, Reitsma JB, et al. Glucose challenge test for detecting gestational diabetes mellitus: a systematic review. BJOG. 2012;119(4):393–401. Epub 2012/01/21.PubMedCrossRefGoogle Scholar
  13. 13.
    Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest. 2005;115(3):485–91. Epub 2005/03/15.PubMedGoogle Scholar
  14. 14.
    Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet. 1998;19(3):268–70. Epub 1998/07/14.PubMedCrossRefGoogle Scholar
  15. 15.
    Wucher H, Lepercq J, Carette C, Colas C, Dubois-Laforgue D, Gautier JF, et al. Poor prognosis of pregnancy in women with autoimmune type 1 diabetes mellitus masquerading as gestational diabetes. Diabetes Metab. 2011;37(1):47–51. Epub 2010/12/04.PubMedCrossRefGoogle Scholar
  16. 16.
    Nilsson C, Ursing D, Torn C, Aberg A, Landin-Olsson M. Presence of GAD antibodies during gestational diabetes mellitus predicts type 1 diabetes. Diabetes Care. 2007;30(8):1968–71. Epub 2007/05/24.PubMedCrossRefGoogle Scholar
  17. 17.
    Rauh-Hain JA, Rana S, Tamez H, Wang A, Cohen B, Cohen A, et al. Risk for developing gestational diabetes in women with twin pregnancies. J Matern Fetal Neonatal Med. 2009;22(4):293–9. Epub 2009/04/03.PubMedCrossRefGoogle Scholar
  18. 18.
    Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med. 2004;21(2):103–13. Epub 2004/02/27.PubMedCrossRefGoogle Scholar
  19. 19.
    Hernandez TL, Friedman JE, Van Pelt RE, Barbour LA. Patterns of glycemia in normal pregnancy: should the current therapeutic targets be challenged? Diabetes Care. 2011;34(7):1660–8. Epub 2011/06/29.PubMedCrossRefGoogle Scholar
  20. 20.
    American Diabetes Association. Standards of medical care in diabetes—2011. Diabetes Care. 2011;34 Suppl 1:S11–61. Epub 2011/01/14.CrossRefGoogle Scholar
  21. 21.
    Hoffman L, Nolan C, Wilson JD, Oats JJ, Simmons D. Gestational diabetes mellitus–management guidelines. The Australasian Diabetes in Pregnancy Society. Med J Aust. 1998;169(2):93–7.PubMedGoogle Scholar
  22. 22.
    Simmons D, McElduff A, McIntyre HD, Elrishi M. Gestational diabetes mellitus: NICE for the U.S.? A comparison of the American Diabetes Association and the American College of Obstetricians and Gynecologists guidelines with the U.K. National Institute for Health and Clinical Excellence guidelines. Diabetes Care. 2010;33(1):34–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Seshiah V, Das AK, Balaji V, Joshi SR, Parikh MN, Gupta S, et al. Gestational diabetes mellitus—guidelines. J Assoc Physicians India. 2006;54:622–8. Epub 2006/09/01.PubMedGoogle Scholar
  24. 24.
    Canadian Diabetes A, Dietitians of C, Diabete Q, Ordre professionnel des dietetistes du Q. Recommendations for nutrition best practice in the management of gestational diabetes mellitus. Executive summary (1). Can J Diet Pract Res. 2006;67(4):206–8. Epub 2006/12/08.CrossRefGoogle Scholar
  25. 25.
    Canadian Diabetes Association. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2008;32:S168–81.Google Scholar
  26. 26.
    Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477–86. Epub 2005/06/14.PubMedCrossRefGoogle Scholar
  27. 27.
    Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361(14):1339–48. Epub 2009/10/03.PubMedCrossRefGoogle Scholar
  28. 28.
    Reader D, Splett P, Gunderson EP, Diabetes C, Education Dietetic Practice G. Impact of gestational diabetes mellitus nutrition practice guidelines implemented by registered dietitians on pregnancy outcomes. J Am Diet Assoc. 2006;106(9):1426–33. Epub 2006/09/12.PubMedCrossRefGoogle Scholar
  29. 29.
    Moses RG, Brand-Miller JC. The use of a low glycaemic index diet in pregnancy: an evolving treatment paradigm. Diabetes Res Clin Pract. 2011;91(1):13–4. Epub 2010/11/27.PubMedCrossRefGoogle Scholar
  30. 30.
    Louie JC, Markovic TP, Perera N, Foote D, Petocz P, Ross GP, et al. A randomized controlled trial investigating the effects of a low-glycemic index diet on pregnancy outcomes in gestational diabetes mellitus. Diabetes Care. 2011;34(11):2341–6. Epub 2011/09/09.PubMedCrossRefGoogle Scholar
  31. 31.
    McElduff A, Moses RG. Insulin therapy in pregnancy. Endocrinol Metab Clin North Am. 2012;41(1):161–73. Epub 2012/05/12.PubMedCrossRefGoogle Scholar
  32. 32.
    Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343(16):1134–8. Epub 2000/10/19.PubMedCrossRefGoogle Scholar
  33. 33.
    Dhulkotia JS, Ola B, Fraser R, Farrell T. Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis. Am J Obstet Gynecol. 2010;203(5):457. e1-9. Epub 2010/08/27.PubMedCrossRefGoogle Scholar
  34. 34.
    Cheng YW, Chung JH, Block-Kurbisch I, Inturrisi M, Caughey AB. Treatment of gestational diabetes mellitus: glyburide compared to subcutaneous insulin therapy and associated perinatal outcomes. J Matern Fetal Neonatal Med. 2012;25(4):379–84. Epub 2011/06/03.PubMedCrossRefGoogle Scholar
  35. 35.
    Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358(19): 2003–15.PubMedCrossRefGoogle Scholar
  36. 36.
    Moore LE, Briery CM, Clokey D, Martin RW, Williford NJ, Bofill JA, et al. Metformin and insulin in the management of gestational diabetes mellitus: preliminary results of a comparison. J Reprod Med. 2007;52(11):1011–5. Epub 2007/12/29.PubMedGoogle Scholar
  37. 37.
    Ijas H, Vaarasmaki M, Morin-Papunen L, Keravuo R, Ebeling T, Saarela T, et al. Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. BJOG. 2011;118(7):880–5. Epub 2010/11/19.PubMedCrossRefGoogle Scholar
  38. 38.
    Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(2):524–9. Epub 2002/02/12.PubMedCrossRefGoogle Scholar
  39. 39.
    De Leo V, Musacchio MC, Piomboni P, Di Sabatino A, Morgante G. The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications. Eur J Obstet Gynecol Reprod Biol. 2011;157(1):63–6. Epub 2011/05/03.PubMedCrossRefGoogle Scholar
  40. 40.
    Glueck CJ, Wang P, Kobayashi S, Phillips H, Sieve-Smith L. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril. 2002;77(3):520–5. Epub 2002/03/02.PubMedCrossRefGoogle Scholar
  41. 41.
    Vanky E, Stridsklev S, Heimstad R, Romundstad P, Skogoy K, Kleggetveit O, et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab. 2010;95(12):E448–55. Epub 2010/10/12.PubMedCrossRefGoogle Scholar
  42. 42.
    Silva JC, Fachin DR, Coral ML, Bertini AM. Perinatal impact of the use of metformin and glyburide for the treatment of gestational diabetes mellitus. J Perinat Med. 2012;40(3):225–8. Epub 2012/04/17.PubMedCrossRefGoogle Scholar
  43. 43.
    Moore LE, Clokey D, Rappaport VJ, Curet LB. Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstet Gynecol. 2010;115(1):55–9. Epub 2009/12/23.PubMedCrossRefGoogle Scholar
  44. 44.
    Silva JC, Pacheco C, Bizato J, de Souza BV, Ribeiro TE, Bertini AM. Metformin compared with glyburide for the management of gestational diabetes. Int J Gynaecol Obstet. 2010;111(1):37–40. Epub 2010/06/15.PubMedCrossRefGoogle Scholar
  45. 45.
    Ogunyemi DA, Fong A, Rad S, Fong S, Kjos SL. Attitudes and practices of healthcare providers regarding gestational diabetes: results of a survey conducted at the 2010 meeting of the International Association of Diabetes in Pregnancy Study Group (IADPSG). Diabet Med. 2011;28(8):976–86. Epub 2011/05/04.PubMedCrossRefGoogle Scholar
  46. 46.
    Simmons D, Walters BNJ, Rowan JA, McIntyre HD. Metformin therapy and diabetes in pregnancy. Med J Aust. 2004;180(9):462–4.PubMedGoogle Scholar
  47. 47.
    Goh JE, Sadler L, Rowan J. Metformin for gestational diabetes in routine clinical practice. Diabet Med. 2011;28(9):1082–7. Epub 2011/06/18.PubMedCrossRefGoogle Scholar
  48. 48.
    Gandhi P, Bustani R, Madhuvrata P, Farrell T. Introduction of metformin for gestational diabetes mellitus in clinical practice: has it had an impact? Eur J Obstet Gynecol Reprod Biol. 2012;160(2):147–50. Epub 2011/12/06.PubMedCrossRefGoogle Scholar
  49. 49.
    Cygalova LH, Hofman J, Ceckova M, Staud F. Transplacental pharmacokinetics of glyburide, rhodamine 123, and BODIPY FL prazosin: effect of drug efflux transporters and lipid solubility. J Pharmacol Exp Ther. 2009;331(3):1118–25. Epub 2009/09/26.PubMedCrossRefGoogle Scholar
  50. 50.
    Hemauer SJ, Patrikeeva SL, Nanovskaya TN, Hankins GD, Ahmed MS. Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin. Am J Obstet Gynecol. 2010;202(4):383. e1-7. Epub 2010/03/31.PubMedCrossRefGoogle Scholar
  51. 51.
    Charles B, Norris R, Xiao X, Hague W. Population pharmacokinetics of metformin in late pregnancy. Ther Drug Monit. 2006;28(1):67–72. Epub 2006/01/19.PubMedCrossRefGoogle Scholar
  52. 52.
    Kovo M, Haroutiunian S, Feldman N, Hoffman A, Glezerman M. Determination of metformin transfer across the human placenta using a dually perfused ex vivo placental cotyledon model. Eur J Obstet Gynecol Reprod Biol. 2008;136(1):29–33. Epub 2007/03/14.PubMedCrossRefGoogle Scholar
  53. 53.
    Kovo M, Kogman N, Ovadia O, Nakash I, Golan A, Hoffman A. Carrier-mediated transport of metformin across the human placenta determined by using the ex vivo perfusion of the placental cotyledon model. Prenat Diagn. 2008;28(6):544–8. Epub 2008/05/30.PubMedCrossRefGoogle Scholar
  54. 54.
    Rowan JA, Rush EC, Obolonkin V, Battin M, Wouldes T, Hague WM. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care. 2011;34(10):2279–84. Epub 2011/09/29.PubMedCrossRefGoogle Scholar
  55. 55.
    Glueck CJ, Salehi M, Sieve L, Wang P. Growth, motor, and social development in breast- and formula-fed infants of metformin-treated women with polycystic ovary syndrome. J Pediatr. 2006;148(5):628–32. Epub 2006/06/02.PubMedCrossRefGoogle Scholar
  56. 56.
    Weiss PA, Hofmann HM, Winter RR, Lichtenegger W, Purstner P, Haas J. Diagnosis and treatment of gestational diabetes according to amniotic fluid insulin levels. Arch Gynecol. 1986;239(2):81–91. Epub 1986/01/01.PubMedCrossRefGoogle Scholar
  57. 57.
    Schaefer-Graf UM, Kjos SL, Buhling KJ, Henrich W, Brauer M, Heinze T, et al. Amniotic fluid insulin levels and fetal abdominal circumference at time of amniocentesis in pregnancies with diabetes. Diabet Med. 2003;20(5):349–54. Epub 2003/05/20.PubMedCrossRefGoogle Scholar
  58. 58.
    Buchanan TA, Kjos SL, Montoro MN, Wu PY, Madrilejo NG, Gonzalez M, et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care. 1994;17(4):275–83. Epub 1994/04/01.PubMedCrossRefGoogle Scholar
  59. 59.
    Kjos SL, Schaefer-Graf U, Sardesi S, Peters RK, Buley A, Xiang AH, et al. A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care. 2001;24(11):1904–10. Epub 2001/10/27.PubMedCrossRefGoogle Scholar
  60. 60.
    Kjos SL, Schaefer-Graf UM. Modified therapy for gestational diabetes using high-risk and low-risk fetal abdominal circumference growth to select strict versus relaxed maternal glycemic targets. Diabetes Care. 2007;30 Suppl 2:S200–5.PubMedCrossRefGoogle Scholar
  61. 61.
    Schaefer-Graf UM, Kjos SL, Fauzan OH, Buhling KJ, Siebert G, Buhrer C, et al. A randomized trial evaluating a predominantly fetal growth-based strategy to guide management of gestational diabetes in Caucasian women. Diabetes Care. 2004;27(2):297–302. Epub 2004/01/30.PubMedCrossRefGoogle Scholar
  62. 62.
    Bonomo M, Cetin I, Pisoni MP, Faden D, Mion E, Taricco E, et al. Flexible treatment of gestational diabetes modulated on ultrasound evaluation of intrauterine growth: a controlled randomized clinical trial. Diabet Metab. 2004;30(3):237–44. Epub 2004/06/30.CrossRefGoogle Scholar
  63. 63.
    Drury MI, Stronge JM, Foley ME, MacDonald DW. Pregnancy in the diabetic patient: timing and mode of delivery. Obstet Gynecol. 1983;62(3):279–82. Epub 1983/09/01.PubMedCrossRefGoogle Scholar
  64. 64.
    Rasmussen MJ, Firth R, Foley M, Stronge JM. The timing of delivery in diabetic pregnancy: a 10-year review. Aust N Z J Obstet Gynaecol. 1992;32(4):313–7. Epub 1992/11/01.PubMedCrossRefGoogle Scholar
  65. 65.
    Landon MB, Langer O, Gabbe SG, Schick C, Brustman L. Fetal surveillance in pregnancies complicated by insulin-dependent diabetes mellitus. Am J Obstet Gynecol. 1992;167(3):617–21. Epub 1992/09/01.PubMedCrossRefGoogle Scholar
  66. 66.
    Gabbe S, Hill L, Schmidt L, Schulkin J. Management of diabetes by obstetrician-gynecologists. Obstet Gynecol. 1998;91(5 Pt 1):643–7. Epub 1998/05/08.PubMedCrossRefGoogle Scholar
  67. 67.
    Boulvain M, Stan C, Irion O. Elective delivery in diabetic pregnant women. Cochrane Database Syst Rev. 2001;2, CD001997. Epub 2001/06/19.PubMedGoogle Scholar
  68. 68.
    Kjos SL, Henry OA, Montoro M, Buchanan TA, Mestman JH. Insulin-requiring diabetes in pregnancy: a randomized trial of active induction of labor and expectant management. Am J Obstet Gynecol. 1993;169(3):611–5. Epub 1993/09/01.PubMedCrossRefGoogle Scholar
  69. 69.
    Gherman RB, Ouzounian JG, Miller DA, Kwok L, Goodwin TM. Spontaneous vaginal delivery: a risk factor for Erb’s palsy? Am J Obstet Gynecol. 1998;178(3):423–7. Epub 1998/04/16.PubMedCrossRefGoogle Scholar
  70. 70.
    Hod M, Bar J, Peled Y, Fried S, Katz I, Itzhak M, et al. Antepartum management protocol. Timing and mode of delivery in gestational diabetes. Diabetes Care. 1998;21 Suppl 2:B113–7. Epub 1998/08/15.PubMedGoogle Scholar
  71. 71.
    Crume TL, Ogden LG, Mayer-Davis EJ, Hamman RF, Norris JM, Bischoff KJ, et al. The impact of neonatal breast-feeding on growth trajectories of youth exposed and unexposed to diabetes in utero: the EPOCH Study. Int J Obes (Lond). 2012;36(4):529–34. doi:10.1038/ijo.2011.254. Epub 2 Jan 31.CrossRefGoogle Scholar
  72. 72.
    O'Reilly M, Avalos G, Dennedy MC, O'Sullivan EP, Dunne FP. Breast-feeding is associated with reduced postpartum maternal glucose intolerance after gestational diabetes. Ir Med J. 2012;105(5 Suppl):31–6.PubMedGoogle Scholar
  73. 73.
    Gunderson EP, Hedderson MM, Chiang V, Crites Y, Walton D, Azevedo RA, et al. Lactation intensity and postpartum maternal glucose tolerance and insulin resistance in women with recent GDM: the SWIFT cohort. Diabetes Care. 2012;35(1):50–6. Epub 2011 Oct 19.PubMedCrossRefGoogle Scholar
  74. 74.
    Oats JJ, McIntyre HD. Revision of guidelines for the management of gestational diabetes mellitus. Med J Aust. 2004;181(6):342. Epub 2004/09/21.PubMedGoogle Scholar
  75. 75.
    Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25(10):1862–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773–9.PubMedCrossRefGoogle Scholar
  77. 77.
    Bentley-Lewis R. Gestational diabetes mellitus: an opportunity of a lifetime. Lancet. 2009;373(9677): 1738–40.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • H. David McIntyre
    • 1
  • Catherine Baskerville
    • 2
  • Jeremy J. N. Oats
    • 3
  1. 1.Obstetric Medicine, Mater Health ServicesUniversity of QueenslandSouth BrisbaneAustralia
  2. 2.Endocrinology, Mater Health ServicesUniversity of QueenslandSouth BrisbaneAustralia
  3. 3.Melbourne School of Population and Global HealthUniversity of MelbourneCarltonAustralia

Personalised recommendations